BioSpace: Biotech, Pharmaceutical and Clinical Research News
WEBBoehringer, Insilico Appear to Break Through Against IPF. Clinical trial results shared by Boehringer Ingelheim and Insilico Medicine showed improvement in idiopathic pulmonary fibrosis, an intractable lung disease for which current treatment options fail to stop progression, but the data were limited, leaving experts wanting. September 24, 2024.
News - BioSpace
WEBSeptember 27, 2024. ·. 8 min read. ·. Heather McKenzie. Load More. BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.
China - BioSpace
WEBWell-financed startup Tome is winding down operations just as two new companies, Borealis Biosciences and GondolaBio, are launching. Meanwhile, in the midst of already tense relations with China, House lawmakers raise the alarm about U.S. companies working with the country’s military on trials. August 28, 2024. ·.
Approvals - BioSpace
WEBSep 23, 2024 · Follow along as BioSpace keeps you up to date on all of the FDA’s decisions in 2024. With Friday’s approval, Sanofi’s anti-CD38 antibody Sarclisa will go head-to-head with the first such therapy for multiple myeloma, Johnson & Johnson’s Darzalex, which raked in nearly $10 billion last year. With …
Asia - BioSpace
WEBHouse Speaker Plans to Vote, Pass BIOSECURE Act into Law This Year. House Speaker Mike Johnson (R-La.) on Monday said he intends to have a “significant package of China-related legislation” signed into law by the end of this year, including the BIOSECURE Act which intends to stop federal contracts with Chinese “companies of concern ...
Clinical research - BioSpace
WEBAug 12, 2024 · Pelage Pharmaceuticals Advances Clinical Program with First Patients Dosed in Phase 2 Study for Hair Loss and GV-Led $14M Series A-1. August 13, 2024. 4 min read. Sionna Therapeutics Announces Initiation of Two Phase 1 Clinical Trials of SION-719 and SION-451, in Development for Cystic Fibrosis.
FDA News: Approvals, Adcomms, Complete Response Letters and ... - BioSpace
WEBApprovals. Adcomms. Complete response letters. Guidances. FDA. FDA Tracker: J&J Scores Third NSCLC Approval for Rybrevant This Year. In 2023, the FDA greenlit 55 new drugs and 34 cell and gene therapies. Follow along as BioSpace keeps you up to date on all of the FDA’s decisions in 2024. September 20, 2024.
About Us - BioSpace
WEBAbout Us. BioSpace is the hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. The proprietary resources we provide help companies make informed decisions regarding their workforce.
All News - BioSpace
WEBFDA Approves New Oral Alzheimer’s Therapy, Expands Label for Grifols’ SCIg Therapy. In 2023, the FDA greenlit 55 new drugs and 34 cell and gene therapies. Follow along as BioSpace keeps you up to date on all of the FDA’s decisions in 2024. July 29, 2024. ·.
Insights - BioSpace
WEBJul 8, 2024 · Press Releases. Anti CD70 Antibodies Clinical Trials Market Opportunity Insight. July 11, 2024. ·. 2 min read. BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and …